Baron Health Care Retail holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Baron Health Care Fund Retail Shares BHCFX
- NAV / 1-Day Return 21.96 / −1.44 %
- Total Assets 114.3M
-
Adj. Expense Ratio
1.100%
- Expense Ratio 1.100%
- Distribution Fee Level Average
- Share Class Type No Load
- Category Health
- Investment Style Mid Growth
- Min. Initial Investment 2,000
- Status Open
- TTM Yield 0.00
- Turnover 74%
USD | NAV as of Jul 11, 2026 | 1-Day Return as of Jul 11, 2026, 12:11 AM GMT+0
Morningstar’s Analysis BHCFX
Will BHCFX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 50.9
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 13.65 | 16M | Healthcare |
Mettler-Toledo International Inc | 5.59 | 6M | Healthcare |
Johnson & Johnson | 5.56 | 6M | Healthcare |
argenx SE ADR | 4.22 | 5M | Healthcare |
Thermo Fisher Scientific Inc | 3.91 | 4M | Healthcare |
Roivant Sciences Ltd Ordinary Shares | 3.87 | 4M | Healthcare |
Teva Pharmaceutical Industries Ltd ADR | 3.86 | 4M | Healthcare |
UnitedHealth Group Inc | 3.64 | 4M | Healthcare |
Welltower Inc | 3.38 | 4M | Real Estate |
RadNet Inc | 3.24 | 4M | Healthcare |
United States